Short and long-term predictors of relapses or disability worsening in patients with multiple sclerosis in the phase 3 TRANSFORMS study

被引：0
|
作者：
Boster, Aaron [1 ]
Repovic, Pavle [2 ]
Meng, Xiangyi [3 ]
Meier, Daniela Piani [4 ]
Boulos, Fernanda [3 ]
Sprenger, Till [5 ,6 ,7 ]
Barkhof, Frederik [8 ]
机构：
[1] OhioHlth Neurol Phys, Columbus, OH USA
[2] Swedish Neurosci Inst, Multiple Sclerosis Ctr, Seattle, WA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
[5] Univ Basel Hosp, Med Image Anal Ctr, Basel, Switzerland
[6] Univ Basel Hosp, Dept Neurol, Basel, Switzerland
[7] DKD HELIOS Klin Wiesbaden, Wiesbaden, Germany
[8] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P170
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [21] The role of relapses affecting the long-term disability outcome in multiple sclerosis in the London Ontario database
    Scalfari, Antonio
    Degenhardt, Alexandra
    Neuhaus, Anneke
    Harner, Nadia
    Seemueller, Silke
    Nicholas, Richaid
    Mularo, Paolo A.
    Daumer, Martin
    Ebers, George
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S198 - S198
  • [22] Prognostic indicators for long-term disability in multiple sclerosis patients
    Damasceno, Alfredo
    Von Glehn, Felipe
    Brandao, Carlos Otavio
    Damasceno, Benito Pereira
    Cendes, Fernando
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 29 - 33
  • [23] The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era
    Scott, Thomas F.
    Bertha, Nicholas
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 413
  • [24] Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis
    Jokubaitis, Vilija G.
    Spelman, Tim
    Kalincik, Tomas
    Lorscheider, Johannes
    Havrdova, Eva
    Horakova, Dana
    Duquette, Pierre
    Girard, Marc
    Prat, Alexandre
    Izquierdo, Guillermo
    Grammond, Pierre
    Van Pesch, Vincent
    Pucci, Eugenio
    Grand'Maison, Francois
    Hupperts, Raymond
    Granella, Franco
    Sola, Patrizia
    Bergamaschi, Roberto
    Iuliano, Gerardo
    Spitaleri, Daniele
    Boz, Cavit
    Hodgkinson, Suzanne
    Olascoaga, Javier
    Verheul, Freek
    McCombe, Pamela
    Petersen, Thor
    Rozsa, Csilla
    Lechner-Scott, Jeannette
    Laura Saladino, Maria
    Farina, Deborah
    Iaffaldano, Pietro
    Paolicelli, Damiano
    Butzkueven, Helmut
    Lugaresi, Alessandra
    Trojano, Maria
    ANNALS OF NEUROLOGY, 2016, 80 (01) : 89 - 100
  • [25] Long-term predictors of clinical outcomes in patients with multiple sclerosis randomized to fingolimod 0.5 mg in the phase 3 FREEDOMS, FREEDOMS II and TRANSFORMS studies
    Sprenger, Till
    Boster, Aaron
    Meng, Xiangyi
    Ritter, Shannon
    Meier, Daniela Piani
    Tomic, Davorka
    Silva, Diego
    Barkhof, Frederik
    Repovic, Pavle
    NEUROLOGY, 2018, 90
  • [26] Predictors of long term disability progression in patients with relapsing remitting multiple sclerosis
    Ignatova, V.
    Todorova, L.
    Haralanov, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 788 - 789
  • [27] The extent of MRI-visible lesions and the short-term evolution of their intrinsic tissue damage predict the long-term worsening of disability in patients with multiple sclerosis
    Agosta, F
    Rovaris, M
    Sormani, MP
    Pulizzi, A
    Martinelli, V
    Comi, G
    Filippi, M
    MULTIPLE SCLEROSIS, 2005, 11 : S142 - S142
  • [28] Prediction of long-term disability in multiple sclerosis
    Schlaeger, R.
    D'Souza, M.
    Schindler, C.
    Grize, L.
    Dellas, S.
    Radue, E. W.
    Kappos, L.
    Fuhr, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (01) : 31 - 38
  • [29] Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study
    Zhang, Yao
    Xu, Yan
    Xu, Tao
    Yin, Hexiang
    Zhu, Yicheng
    Peng, Bin
    Cui, Liying
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [30] A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod
    Salter, Amber
    Lancia, Samantha
    Cutter, Gary
    Marrie, Ruth Ann
    Mendoza, Jason P.
    Lewin, James B.
    Mellen, Robert J. Fox
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
12345